New Podcast Listen
Providers
Order Test
Platform
Patients
About Psoriasis
Mindera Assist Program
Company
News
Team
Careers
Contact Us
Menu
Providers
Order Test
Platform
Patients
About Psoriasis
Mindera Assist Program
Company
News
Team
Careers
Contact Us
August 19, 2024
Mindera Health™ becomes a Medi-Cal™ Credentialled Provider
August 12, 2024
Mindera Health Announces Appointment of Kamal Adawi as Chief Financial Officer
July 31, 2024
Mindera Health Secures $14 Million to Advance Commercialization of First and Only Psoriasis Precision Medicine Test
March 11, 2024
THE LOCALIST SD Precision Medicine disrupts the medical world
February 29, 2024
Mindera Health™ Launches Program with Innovative Pharmacy Benefit Manager to Improve Management of Moderate-to-Severe Psoriasis Patients Through Precision Medicine
November 27, 2023
Mindera Health ™ Announces Commercial Relocation
November 6, 2023
Mindera Health ™ announces the signing of a commercial agreement with Occum Health for Mind.Px ™
October 23, 2023
Mindera Inc. Signs Provider Contract with Provider Network Contigo Health ConfigureNet(™)
October 16, 2023
Mindera Health™ Announces Issuance of Additional International Patent Coverage for Dermal Biomarker Patch Platform
October 10, 2023
Mindera Health™ Announces Contract With General Services Administration®
October 3, 2023
Mindera Health™ Signs Contract with Nationwide Provider Network MediNcrease™
May 11, 2023
Mindera Health™ Announces Change to Executive Leadership Team
April 10, 2023
Mindera Health™ Announces Coverage with Evidence Project with Highmark, Inc. to Advance Moderate-to-Severe Psoriasis Patient Care and Reduce Specialty Drug Spending
March 14, 2023
Mindera Health™ Appoints Linh H. Le as Chief Financial Officer and Chief Operating Officer
December 12, 2022
Mindera Health™ Closes Upsized $20M Series A-3 Financing
October 20, 2022
Interim Results of MATCH Study Demonstrate Improved Decision Making and Clinical Outcomes When Using Mind.Px™ to Determine Biologic Drug Class for Psoriasis Patients
July 26, 2022
Mindera Health™ announces publication of a consensus panel opinion that positive results from the MATCH Study would prove clinical utility for precision medicine test Mind.Px™
April 28, 2022
Mindera Health™ Launches Pilot with National Health Insurance Company to Improve Management of Moderate-To-Severe Psoriasis Patients Through Precision Medicine
March 1, 2022
Mindera Health™ Appoints Deborah L. Rice-Johnson to its Board of Directors
January 4, 2022
Mindera Health™ and WellDyne announce a definitive agreement to improve management of moderate-to-severe psoriasis patients
November 16, 2021
Mindera Health™ announces publication of positive results from STAMP-1 and STAMP-2 studies
October 21, 2021
Mindera Health™ announces first patient enrolled in the MATCH Study; a clinical utility evaluation of the impact of Mind.Px™ on response rates of psoriasis patients who are prescribed biologics
October 5, 2021
Mindera Corporation Shifts Name to Mindera Health to Sharpen Focus on Its Personalized Medicine Platform
August 2, 2021
Dermatology Industry Veteran Ann Deren-Lewis Joins Mindera as Chief Commercial Officer
July 26, 2021
Mindera Survey Confirms the Impact of Physician Trial-and-Error Behavior on Psoriasis Biologic Treatment
July 19, 2021
Mindera ™ announces publication of an economic evaluation of precision medicine testing for the treatment of psoriasis
May 11, 2021
Mindera Raises Over $12M Series A-2 Financing
May 6, 2021
Mindera™ Honored as Winner in 2021 MedTech Breakthrough Awards Program, Best New Technology Solution – Dermatology
January 25, 2021
Mindera wins Prestigious Terra2 Skin Health Innovations Competition at 2021 Winter Clinical Dermatology Conference
January 12, 2021
Mindera Selected as Finalist in Terra2 Solutions Skin Health Innovation Competition at Winter Clinical Dermatology Conference
January 6, 2021
Mindera to Present Precision Medicine Test for Psoriasis Biologics at Dermatology Summit 2021
August 11, 2020
Mindera Announces CLIA Certification Achieved by its Diagnostics Laboratory
July 27, 2020
Mindera Corporation Announces Appointment of George W. Mahaffey as President and Chief Executive Officer
November 14, 2019
Mindera Corporation Raises $5.3M Series A to Commercialize Psoriasis Biologic Responsiveness Test
Providers
Order Test
Platform
Patients
About Psoriasis
Mindera Assist Program
Company
News
Team
Careers
Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok
Privacy policy
